Filing Details

Accession Number:
0001593968-21-001243
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-06 13:00:00
Reporting Period:
2021-05-05
Accepted Time:
2021-05-06 18:20:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635616 G. Dirk Brockstedt C/O Rapt Therapeutics, Inc.,
561 Eccles Avenue
South San Francisco CA 94080
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-05 2,084 $21.56 19,812 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
  2. Includes 2,084 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on April 30, 2021.